missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18400107

DOK7 Antibody (OTI2C12), DyLight 594, Novus Biologicals™

Product Code. 18400107 Shop All Bio Techne Products
Change view
Click to view available options
Quantity:
0.1 mL
Unit Size:
0.10mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
18400107 0.1 mL 0.10mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 18400107 Supplier Novus Biologicals Supplier No. NBP272491DL594

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

DOK7 Monoclonal antibody specifically detects DOK7 in Human samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY

Specifications

Antigen DOK7
Applications Western Blot
Classification Monoclonal
Clone OTI2C12
Conjugate DyLight 594
Formulation 50mM Sodium Borate
Gene Alias C4orf25chromosome 4 open reading frame 25, CMS1B, docking protein 7, Dok-7, Downstream of tyrosine kinase 7, FLJ33718, FLJ39137, FLJ90556, protein Dok-7
Host Species Mouse
Immunogen Full length recombinant protein of human DOK7 (NP_775931) produced in HEK293T cells.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 285489
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.